Changchun BCHT Biotechnology Co.

SHSE:688276 Stock Report

Market Cap: CN¥11.1b

Changchun BCHT Biotechnology Valuation

Is 688276 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688276 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688276 (CN¥26.93) is trading above our estimate of fair value (CN¥6.43)

Significantly Below Fair Value: 688276 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688276?

Key metric: As 688276 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688276. This is calculated by dividing 688276's market cap by their current earnings.
What is 688276's PE Ratio?
PE Ratio26.9x
EarningsCN¥414.29m
Market CapCN¥11.14b

Price to Earnings Ratio vs Peers

How does 688276's PE Ratio compare to its peers?

The above table shows the PE ratio for 688276 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.7x
300685 Amoy Diagnostics
32.5x19.6%CN¥10.2b
688336 Sunshine Guojian Pharmaceutical (Shanghai)
39.2x-11.7%CN¥14.3b
300009 Anhui Anke Biotechnology (Group)
19.7x16.7%CN¥15.4b
600645 Vcanbio Cell & Gene Engineering
87.3x23.0%CN¥9.4b
688276 Changchun BCHT Biotechnology
26.9x40.7%CN¥11.1b

Price-To-Earnings vs Peers: 688276 is good value based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (44.7x).


Price to Earnings Ratio vs Industry

How does 688276's PE Ratio compare vs other companies in the CN Biotechs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688276 26.9xIndustry Avg. 36.4xNo. of Companies6PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688276 is good value based on its Price-To-Earnings Ratio (26.9x) compared to the CN Biotechs industry average (36.4x).


Price to Earnings Ratio vs Fair Ratio

What is 688276's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688276 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio26.9x
Fair PE Ratio37x

Price-To-Earnings vs Fair Ratio: 688276 is good value based on its Price-To-Earnings Ratio (26.9x) compared to the estimated Fair Price-To-Earnings Ratio (37x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688276 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥26.93
CN¥31.99
+18.8%
0.05%CN¥32.00CN¥31.97n/a2
Nov ’25CN¥25.45
CN¥39.37
+54.7%
26.5%CN¥54.13CN¥31.97n/a3
Oct ’25CN¥30.60
CN¥39.37
+28.6%
26.5%CN¥54.13CN¥31.97n/a3
Sep ’25CN¥24.35
CN¥39.37
+61.7%
26.5%CN¥54.13CN¥31.97n/a3
Aug ’25CN¥29.89
CN¥54.57
+82.6%
0.8%CN¥55.00CN¥54.13n/a2
Jul ’25CN¥31.09
CN¥54.57
+75.5%
0.8%CN¥55.00CN¥54.13n/a2
Jun ’25CN¥34.00
CN¥54.57
+60.5%
0.8%CN¥55.00CN¥54.13n/a2
May ’25CN¥39.07
CN¥54.57
+39.7%
0.8%CN¥55.00CN¥54.13n/a2

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies